Beijing Mabworks Biotech Co., Ltd.
Works in Cardiovascular · Dermatology · Hematology · Immunology · Neurology · Oncology · Ophthalmology · Renal & urogenital · Respiratory · Women's health
Beijing Mabworks Biotech Co., Ltd. is a clinical trial sponsor. It has 12 active clinical trials with 1,462 planned participants, across 10 therapeutic areas. Since 2021 it has completed 3 trials and stopped 0 early.
Trial track record · since 2021
Pipeline · 12 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Beijing Mabworks Biotech Co., Ltd
Beijing Mabworks Biotech Co., Ltd is lead sponsor of 12 active clinical trials on ClinicalTrials.gov, with 1,462 planned participants, in Cardiovascular, Dermatology, Hematology, Immunology and other areas. Since 2021 it has completed 3 trials and stopped 0 early.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Beijing Mabworks Biotech Co., Ltd; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-05-05.
Approve Suite is not affiliated with Beijing Mabworks Biotech Co., Ltd..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.